PlusTherapeuticsInc . (NASDAQ:PSTV) Trading Up 7%

PlusTherapeuticsInc . (NASDAQ:PSTV) shares were up 7% during mid-day trading on Thursday . The company traded as high as $9.49 and last traded at $8.36, approximately 321,937 shares changed hands during trading. An increase of 108% from the average daily volume of 154,542 shares. The stock had previously closed at $7.81.

The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.37 and a current ratio of 0.38.

PlusTherapeuticsInc . (NASDAQ:PSTV) last issued its quarterly earnings data on Thursday, August 15th. The company reported ($5.12) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($9.75) by $4.63. The business had revenue of $0.30 million for the quarter. PlusTherapeuticsInc . had a negative return on equity of 546.87% and a negative net margin of 492.45%.

About PlusTherapeuticsInc . (NASDAQ:PSTV)

Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, engages in developing treatments for cancer and other diseases in the United States. The company's lead product candidate in pipeline is DocePLUS, an albumin-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer.

Read More: Average Daily Trade Volume – ADTV

Receive News & Ratings for PlusTherapeuticsInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PlusTherapeuticsInc . and related companies with's FREE daily email newsletter.